# Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders

> **NCT06941636** · PHASE3 · RECRUITING · sponsor: **Region Stockholm** · enrollment: 90 (estimated)

## Conditions studied

- Temporomandibular Disorder

## Interventions

- **DRUG:** 5U/0,1 ml Botulinum toxin A
- **DRUG:** 10U/0,1 ml Botulinum toxin A

## Key facts

- **NCT ID:** NCT06941636
- **Lead sponsor:** Region Stockholm
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06941636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06941636, "Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06941636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*